Open access peer-reviewed chapter

Nanocarriers for Cytosolic Drug and Gene Delivery in Cancer Therapy

By Srinath Palakurthi, Venkata K. Yellepeddi and Ajay Kumar

Submitted: April 9th 2010Published: January 8th 2011

DOI: 10.5772/12918

Downloaded: 2499

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike-3.0 License, which permits use, distribution and reproduction for non-commercial purposes, provided the original is properly cited and derivative works building on this content are distributed under the same license.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Srinath Palakurthi, Venkata K. Yellepeddi and Ajay Kumar (January 8th 2011). Nanocarriers for Cytosolic Drug and Gene Delivery in Cancer Therapy, Biomedical Engineering, Trends, Research and Technologies, Malgorzata Anna Komorowska and Sylwia Olsztynska-Janus, IntechOpen, DOI: 10.5772/12918. Available from:

chapter statistics

2499total chapter downloads

2Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Antimicrobial Peptides: Diversity and Perspectives for Their Biomedical Application

By Joel E. López-Meza, Alejandra Ochoa-Zarzosa José A. Aguilar and Pedro D. Loeza-Lara

Related Book

First chapter

Biomedical Engineering Professional Trail from Anatomy and Physiology to Medicine and Into Hospital Administration: Towards Higher-Order of Translational Medicine and Patient Care

By Dhanjoo N. Ghista

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us